Quest Diagnostics (DGX) Gross Profit: 2009-2025
Historic Gross Profit for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $949.0 million.
- Quest Diagnostics' Gross Profit rose 17.02% to $949.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.6 billion, marking a year-over-year increase of 15.73%. This contributed to the annual value of $3.2 billion for FY2024, which is 6.26% up from last year.
- Latest data reveals that Quest Diagnostics reported Gross Profit of $949.0 million as of Q3 2025, which was up 0.64% from $943.0 million recorded in Q2 2025.
- Quest Diagnostics' Gross Profit's 5-year high stood at $1.1 billion during Q3 2021, with a 5-year trough of $736.0 million in Q4 2023.
- Over the past 3 years, Quest Diagnostics' median Gross Profit value was $804.0 million (recorded in 2024), while the average stood at $822.9 million.
- Its Gross Profit has fluctuated over the past 5 years, first surged by 98.19% in 2021, then fell by 26.12% in 2022.
- Quest Diagnostics' Gross Profit (Quarterly) stood at $1.0 billion in 2021, then declined by 26.12% to $758.0 million in 2022, then dropped by 2.90% to $736.0 million in 2023, then climbed by 16.58% to $858.0 million in 2024, then increased by 17.02% to $949.0 million in 2025.
- Its last three reported values are $949.0 million in Q3 2025, $943.0 million for Q2 2025, and $863.0 million during Q1 2025.